Tygacil Drug Use Investigation (TIGER)

Pfizer logo

Pfizer

Status

Completed

Conditions

Skin Disease, Infectious
Intra-Abdominal Infections

Treatments

Drug: Tigecycline (Tygacil)

Study type

Observational

Funder types

Industry

Identifiers

NCT01789905
B1811187

Details and patient eligibility

About

Secondary Data Collection Study; safety and effectiveness of Tigecycline .under Japanese medical practice

Enrollment

116 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients who are prescribed tigecycline (Tygacil).

Exclusion criteria

  • Subject who have not been prescribed tigecycline (Tygacil).

Trial design

116 participants in 1 patient group

Tigecycline (Tygacil)
Description:
Subjects who are treated with tigecycline
Treatment:
Drug: Tigecycline (Tygacil)

Trial documents
2

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems